Stephen E. Zale
Impact in
- Pharmaceutical Science top 1%
- Advanced Drug Delivery Systems
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Protein purification and stability 4
- RNA Interference and Gene Delivery 2
- Protein Structure and Dynamics 2
-
- Nanoparticle-Based Drug Delivery 6
- Co-authors
- Alexander M. Klibanov (4 shared papers)Mark A. Tracy (3 shared papers)Randal A. Goffe (1 shared paper)Alexander M. Klibanov (1 shared paper)Henry R. Costantino (3 shared papers)Kai Griebenow (2 shared papers)Karen G. Carrasquillo (2 shared papers)Donald M. Parsons (3 shared papers)
- Journals
- The AAPS Journal (2 papers)Biotechnology and Bioengineering (2 papers)Nature Biotechnology (2 papers)Journal of Pharmaceutical Sciences (2 papers)Journal of Controlled Release (2 papers)
- Partner nations
- United StatesIrelandPuerto Rico
In The Last Decade
Stephen E. Zale
18 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 123
- Pharmaceutical Science 248
- Biomaterials 467
- Molecular Biology 851
- Biomedical Engineering 487
- Food Science 178
Countries citing papers authored by Stephen E. Zale
This map shows the geographic impact of Stephen E. Zale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen E. Zale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen E. Zale more than expected).
Fields of papers citing papers by Stephen E. Zale
This network shows the impact of papers produced by Stephen E. Zale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen E. Zale. The network helps show where Stephen E. Zale may publish in the future.
Co-authors
The 25 scholars most cited alongside Stephen E. Zale, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1986 | 245 | |
| 2 | 1988 | 234 | |
| 3 | 2016 | 220 | |
| 4 | 2000 | 154 | |
| 5 | 2002 | 109 | |
| 6 | 2016 | 104 | |
| 7 | 1998 | 98 | |
| 8 | 1983 | 85 | |
| 9 | 2016 | 74 | |
| 10 | 1997 | 69 | |
| 11 | 2010 | 60 | |
| 12 | 2017 | 54 | |
| 13 | 1982 | 53 | |
| 14 | 2016 | 46 | |
| 15 | 2016 | 46 | |
| 16 | 2004 | 28 | |
| 17 | 1984 | 14 | |
| 18 | 2022 | 1 | |
| 19 | 1982 | 0 |
About Stephen E. Zale
Stephen E. Zale is a scholar working on Molecular Biology, Biomaterials, Biomedical Engineering, Materials Chemistry and Food Science, having authored 19 papers that have together received 1.7k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (6 papers), Microencapsulation and Drying Processes (4 papers), Protein purification and stability (4 papers), Inhalation and Respiratory Drug Delivery (2 papers), RNA Interference and Gene Delivery (2 papers), Nanoparticles: synthesis and applications (2 papers), Protein Structure and Dynamics (2 papers) and Advanced Drug Delivery Systems (2 papers). The work is most often cited by research in Pharmaceutical Science (248 citations), Biomaterials (467 citations), Molecular Biology (851 citations), Biomedical Engineering (487 citations) and Food Science (178 citations). Stephen E. Zale has collaborated with scholars based in United States, Ireland and Puerto Rico. Frequent co-authors include Alexander M. Klibanov, Mark A. Tracy, Randal A. Goffe, Alexander M. Klibanov, Henry R. Costantino, Kai Griebenow, Karen G. Carrasquillo, Donald M. Parsons, Hagop Youssoufian and Raymond T. Bartus. Their work appears in journals such as The AAPS Journal, Biotechnology and Bioengineering, Nature Biotechnology, Journal of Pharmaceutical Sciences and Journal of Controlled Release.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.